Streamlining Development To Production In Pharma With CDMOs
Based on current market analyses, global pharmaceutical spending is projected to reach approximately $1,742 billion by 2025. Concurrently, spending on COVID-19 vaccines and therapeutics...
Reviving UK-EU Research Collaboration With Horizon Europe
The United Kingdom has once again become a part of Horizon Europe through a fresh agreement with the European Union. This development opens up...
Developing Pharma Skills With Life Sci For Growth Initiative
The UK government dedicates £5.5 million towards establishing a Medicines Manufacturing Skills Centre of Excellence. This center aims to bolster the pool of skilled...
Antibiotic Waste Management In Pharmaceutical Manufacturing
In 2023, the pharmaceutical industry, particularly antibiotic manufacturers, has experienced a range of changes that span from supply chain challenges to new regulatory opportunities....
CDMO Strategies Are Key To Success In The Biopharma Sector
In the biopharma industry, selecting the right contract development and manufacturing organization (CDMO) is pivotal to a successful pharmaceutical development journey. This decision hinges...
Rising Demand For CDMOs Amid COVID-19 Reshaping API Market
The API CDMO market underwent significant changes due to the COVID-19 pandemic. The global rollout of vaccines and therapeutics against the virus led to...
Optimizing CDMO Competitiveness Through Pricing Innovation
Contract Development and Manufacturing Organizations (CDMOs), which pharmaceutical companies increasingly delegate product development and manufacturing, operate in a fragmented market undergoing substantial consolidation. Yet,...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...